The decision made with regard to this NICE 30 day TA can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/

  • TA929 – Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction

The following guideline approved at October 2023 Medicines Subcommittee has now been published and can be found at: